Medical Weight Loss for Pawtucket, Rhode Island Residents

Pawtucket, Rhode Island residents get physician-supervised weight loss by telehealth from New Hope Weight Loss: a $119 doctor review, then compounded semaglutide from $166/month or tirzepatide from $233/month.

Physician-supervised GLP-1 programs from $166/month, serving Pawtucket through telehealth from our Costa Mesa, California clinic. Doctor review $119. Over 5,400 patients treated.

Skip the commute, keep the care: from the greater Pawtucket area and the Providence metro and anywhere else in Pawtucket, you meet your physician on a video call from home or work. We confirm telehealth eligibility during the consultation. Doctor review just $119 (medication separate).

Why Pawtucket Residents Choose New Hope Weight Loss

Trust comes down to who is responsible and whether the price is straight, and on both counts New Hope gives Pawtucket a clear answer. Dr. Anjmun Sharma, MD personally oversees your care, the pricing is flat and posted, and the whole program reaches you by telehealth from Costa Mesa with no insurance required and no distance surcharge. A named physician, an honest number, and care that comes to you across Rhode Island. That is the entire promise, and we keep it.

Pawtucket is part of the area New Hope Weight Loss serves by telehealth. The same compounded semaglutide and tirzepatide protocols, the same flat pricing, and the same bilingual support reach Pawtucket patients at home.

New Hope Weight Loss is based in Costa Mesa, yet a patient in Pawtucket sees the same doctor, takes the same approach, and pays the same prices, all through telehealth across Rhode Island. We care for patients throughout the greater Pawtucket area and the Providence metro. You can have your first video visit from your kitchen in Pawtucket and have your treatment plan in motion the same week.

A patient in the busiest part of Pawtucket and one in a quiet Rhode Island suburb pay exactly the same: $119 for the physician review and semaglutide from $166 per month. Because every Pawtucket visit happens by video, there is no local office to drive to and no travel cost added to your $119 review. Though Rhode Island is the smallest state, our reach there is complete: New Hope Weight Loss cares for patients statewide by telehealth from our Costa Mesa, California clinic.

GLP-1 Weight Loss Programs Available

The 90-Day Metabolic Reset (Semaglutide)

Think of this as a focused three-month plan. Semaglutide carries the same active ingredient as Wegovy and Ozempic, and the branded versions averaged about 15 to 17 percent body-weight loss in trials. Pricing is from $166/mo, with the full 90 days at $499, and Dr. Sharma adjusts your dose along the way. Compounded semaglutide is not FDA-approved, not brand-identical, and individual results vary.

Advanced Program (Tirzepatide)

From $233/mo, tirzepatide engages two metabolic pathways, GLP-1 and GIP. Trials of the branded drug reached up to 22.5 percent loss at higher qualifying doses, a best-case figure rather than the norm. Shares an active ingredient with Mounjaro and Zepbound.

Doctor review: $119. Medication billed separately. HSA, FSA, Klarna, and Affirm welcome for Pawtucket telehealth patients.

How Telehealth Works for Pawtucket

Step 1. Complete the online intake and weight-history quiz from your phone or laptop.

Step 2. Dr. Sharma reviews everything and meets you over secure video, typically within 48 hours, to confirm whether compounded semaglutide or tirzepatide makes sense for you.

Step 3. If appropriate, a state-licensed 503(a) pharmacy ships your medication to your Pawtucket home in insulated cold-pack packaging.

Step 4. You check in by video for follow-ups, so adjusting your dose never means a drive across .

Frequently Asked Questions, Pawtucket

I live in Pawtucket. Is the nearest New Hope Weight Loss office close by?

The nearest office is in Costa Mesa, California, which is our only physical site. That said, you do not have to be near it. We treat Pawtucket, Rhode Island patients by telehealth, and a video consult with Dr. Anjmun Sharma confirms whether you are a candidate for compounded semaglutide or tirzepatide.

Will I ever need to show up in person if I am in Pawtucket?

No in-person visits are needed for Pawtucket residents. The entire program is telehealth, from your first consult to refills and check-ins. When you qualify, your medication ships to Pawtucket in cold-pack packaging designed to maintain the proper temperature throughout shipping.

What are the prices for Pawtucket residents?

A physician review costs $119. Compounded semaglutide is priced from $166 per month or $499 for a 90-day course, and tirzepatide from $233 per month. Medication is charged on its own. Payment through HSA, FSA, Klarna, or Affirm is accepted, and we never add a distance surcharge for Pawtucket.

What areas of Pawtucket do you serve?

We serve patients from across Pawtucket by telehealth, including the greater Pawtucket area and the Providence metro.

Is bilingual (Spanish) telehealth care available for Pawtucket patients?

Yes. Anamaria Schmidt, our bilingual clinical coordinator, handles calls, WhatsApp, and Spanish-language consultations, with Dr. Sharma supervising every case. The full telehealth program, intake, consultation, and follow-up, is available in Spanish for Pawtucket patients.

Pawtucket Residents, Get Started Today

Doctor review $119. Semaglutide from $166/mo. Tirzepatide from $233/mo. Medication separate.

Start My Journey →

New Hope Weight Loss | clinic at 1503 South Coast Drive, Suite 322, Costa Mesa, CA 92626 | (657) 837-3342 | Serving Pawtucket, Rhode Island by telehealth. Telehealth availability and eligibility are confirmed during the medical consultation.

Wegovy® and Ozempic® are registered trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are registered trademarks of Eli Lilly and Company. New Hope Weight Loss is not affiliated with or endorsed by these companies. Compounded semaglutide and tirzepatide are prepared by licensed U.S. pharmacies and are not FDA-approved, not brand-identical, and not reviewed by the FDA for safety, effectiveness, or quality.